Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: 2025’S biggest launches; 2024 deal metrics declined; GSK’s meningococcal vaccine; Arcus’s kidney cancer results; and Novartis on its India hub.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Scrip's Five Must-Know Things

More from Scrip